Citation Impact
Citing Papers
Effective Treatment of Metastatic Forms of Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy
2012
Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
2013
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Interferon- γ Control of EBV-Transformed B Cells: A Role for CD8 + T Cells That Poorly Kill EBV-Infected Cells
2002
Fluctuations of Epstein-Barr Virus Serological Antibodies and Risk for Nasopharyngeal Carcinoma: A Prospective Screening Study with a 20-Year Follow-Up
2011
Microglial Dysregulation in Psychiatric Disease
2013
Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health
2018
Microbiota in health and diseases
2022 Standout
Bacterial Metabolite Indole Modulates Incretin Secretion from Intestinal Enteroendocrine L Cells
2014
The role of short chain fatty acids in appetite regulation and energy homeostasis
2015
SCFAs strongly stimulate PYY production in human enteroendocrine cells
2018
Nasopharyngeal carcinoma
2005 Standout
DNA methylation and the Epstein–Barr virus
1999
Overexpression of Glutathione Reductase but Not Glutathione Synthetase Leads to Increases in Antioxidant Capacity and Resistance to Photoinhibition in Poplar Trees
1995
Short-chain fatty acids suppress food intake by activating vagal afferent neurons
2018
Immunotherapy for Epstein-Barr Virus-Associated Cancers
1998
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
1995
Microbial tryptophan catabolites in health and disease
2018 Standout
Global Cancer Statistics, 2002
2005 Standout
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
1999 Standout
Target mimicry provides a new mechanism for regulation of microRNA activity
2007 Standout
Epstein–Barr virus in the pathogenesis of NPC
2002
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants
2010 Standout
Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice
2021
pGreen: a versatile and flexible binary Ti vector for Agrobacterium-mediated plant transformation
2000
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Impaired Long‐term T Cell Immunity to Epstein‐Barr Virus in Patients with Nasopharyngeal Carcinoma
1992
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Localization of the Major NF-κB-activating Site and the Sole TRAF3 Binding Site of LMP-1 Defines Two Distinct Signaling Motifs
1997 Nobel
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
Nasopharyngeal carcinoma
2019 Standout
The Role of the Immune System in Metabolic Health and Disease
2017
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
2016 Standout
Epstein-Barr Virus Infections in Children After Transplantation of the Small Intestine
1998
Gut microbiome and health: mechanistic insights
2022 Standout
Psychobiotics and the Manipulation of Bacteria–Gut–Brain Signals
2016
Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer
2018
Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy
2007
A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
2014 StandoutNobel
Epstein-Barr virus: exploiting the immune system
2001 Standout
Clonal Proliferations of Cells Infected with Epstein–Barr Virus in Preinvasive Lesions Related to Nasopharyngeal Carcinoma
1995
Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms?
2014
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data
1997
Nasopharyngeal carcinoma
2015 Standout
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
A model for persistent infection with Epstein-Barr virus: The stealth virus of human B cells
1999
The Association of Epstein–Barr Virus with Smooth-Muscle Tumors Occurring after Organ Transplantation
1995
Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods
2016
EBV-Infected B Cells in Infectious Mononucleosis
2000
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma
2001
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Targeting the Enteric Nervous System to Treat Metabolic Disorders? “Enterosynes” as Therapeutic Gut Factors
2019
Impact of Intestinal Peptides on the Enteric Nervous System: Novel Approaches to Control Glucose Metabolism and Food Intake
2018
Epstein–Barr virus: 40 years on
2004 Standout
Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma
1999
Molecular Basis of Latency in Pathogenic Human Viruses
1991 Science
Detection of Epstein-Barr Virus in Invasive Breast Cancers
1999
B cells under influence: transformation of B cells by Epstein–Barr virus
2003
Contrasting Roles of Dendritic Cells and B Cells in the Immune Control of Epstein-Barr Virus
2003
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Notch–RBP-J signaling is involved in cell fate determination of marginal zone B cells
2002 StandoutNobel
The PIN auxin efflux facilitator network controls growth and patterning in Arabidopsis roots
2005 StandoutNature
Short-chain fatty acids in control of body weight and insulin sensitivity
2015 Standout
The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages
2017
Epstein–Barr virus and oncogenesis: from latent genes to tumours
2003
Contribution of the Epstein–Barr virus to the molecular pathogenesis of Hodgkin lymphoma
2007
Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial
2017
Kaposi sarcoma-associated herpesvirus (KSHV): Molecular biology and oncogenesis
2009
Integral membrane protein 2 of Epstein—barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases
1995
EBV Persistence in Memory B Cells In Vivo
1998
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways
1996 Standout
Three transcriptionally distinct forms of epstein-barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promoter usage
1992
Transcriptional regulation by the phosphorylation-dependent factor CREB
2001 Standout
A simple and rapid method for the preparation of plant genomic DNA for PCR analysis
1991 Standout
Molecular Diagnosis of Epstein-Barr Virus-Related Diseases
2001
Epstein–Barr virus–associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2
2002
Clinically Significant Drug Interactions with Newer Antidepressants
2011
The pros, cons, and many unknowns of probiotics
2019 Standout
The Association of Epstein-Barr Virus (Ebv) with T Cell Lymphoproliferations and hodgkin's Disease: Two New Developments in the Ebv Field
1993
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Epstein–Barr Virus Infection
2000 Standout
Microbial regulation of organismal energy homeostasis
2018
Human gut microbiome: hopes, threats and promises
2018
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein–Barr virus nuclear antigen 1
1997 StandoutNobel
A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers
1999
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
1996 Standout
Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies.
2000
Epstein-Barr Virus Latent Membrane Protein 2A Regulates c-Jun Protein through Extracellular Signal-Regulated Kinase
2002
Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes
1992
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Expression of epstein-barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV.
1996
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients
2006
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Tonsillar memory B cells, latently infected with Epstein–Barr virus, express the restricted pattern of latent genes previously found only in Epstein–Barr virus-associated tumors
2000
BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes
1995
Different Patterns of Epstein-Barr Virus Latency in Endemic Burkitt Lymphoma (BL) Lead to Distinct Variants within the BL-Associated Gene Expression Signature
2012
Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure
1993
Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus [see comments]
1993
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
1992
Antisense to the Epstein-Barr Virus (EBV)-Encoded Latent Membrane Protein 1 (LMP-1) Suppresses LMP-1 and Bcl-2 Expression and Promotes Apoptosis in EBV-Immortalized B Cells
1998
Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8+ Killer T Cells
2001 StandoutNobel
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.
1996
Immunohistochemical Detection of the Epstein-Barr Virus–Encoded Latent Membrane Protein 2A in Hodgkin's Disease and Infectious Mononucleosis
1997
Short chain fatty acids in human gut and metabolic health
2020
Cells Expressing the Epstein-Barr Virus Growth Program Are Present in and Restricted to the Naive B-Cell Subset of Healthy Tonsils
2000
Mature dendritic cells pulsed with freeze–thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte responses
2000
Infection of human endothelial cells with Epstein-Barr virus.
1995
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Mature dendritic cells pulsed with freeze–thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte responses
2000
NF-κB inhibition causes spontaneous apoptosis in Epstein–Barr virus-transformed lymphoblastoid cells
2000
Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus
1995
Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium
2015
Dendritic Cells Transduced with an Adenovirus Vector Encoding Epstein-Barr Virus Latent Membrane Protein 2B: a New Modality for Vaccination
1999
Epstein‐Barr virus‐associated Hodgkin's disease: Epidemiologic characteristics in international data
1997
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions
1992
BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders [see comments]
1996
Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease
1995
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-kappa B/Rel family proteins
1995
Expression of Epstein-Barr Virus BamHI-A Rightward Transcripts in Latently Infected B Cells From Peripheral Blood
1999
Activated Notch1 Modulates Gene Expression in B Cells Similarly to Epstein-Barr Viral Nuclear Antigen 2
2000
X-Linked Agammaglobulinemia Patients Are Not Infected with Epstein-Barr Virus: Implications for the Biology of the Virus
1999
Mimicry of CD40 Signals by Epstein-Barr Virus LMP1 in B Lymphocyte Responses
1999 Science
Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state
1994
RBP-L, a Transcription Factor Related to RBP-Jκ
1997 StandoutNobel
Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68.
1994
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Stimulation of GLP-1 Secretion Downstream of the Ligand-Gated Ion Channel TRPA1
2014
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
2000 StandoutNobel
Epstein-Barr Virus LMP2A Transforms Epithelial Cells, Inhibits Cell Differentiation, and Activates Akt
2000
Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein.
1994
Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus
1995
Epstein-Barr Virus and the Somatic Hypermutation of Immunoglobulin Genes in Burkitt's Lymphoma Cells
2001
SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
2006
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
1996 Standout
Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma
2011
The Gut Microbiome Influences Host Endocrine Functions
2019
Cytokine production in the immune response to murine gammaherpesvirus 68
1996 StandoutNobel
A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1
1995
Gut chemosensing mechanisms
2015
Endogenously Expressed nef Uncouples Cytokine and Chemokine Production from Membrane Phenotypic Maturation in Dendritic Cells
2002 StandoutNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.
1995
Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma.
2002
Methylation of Transcription Factor Binding Sites in the Epstein-Barr Virus Latent Cycle Promoter Wp Coincides with Promoter Down-Regulation during Virus-Induced B-Cell Transformation
2000
Gut microbiome, endocrine control of gut barrier function and metabolic diseases
2020
Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes
1994
Matrix Metalloproteinase 9 Expression Is Induced by Epstein-Barr Virus Latent Membrane Protein 1 C-Terminal Activation Regions 1 and 2
1999
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of Lucy Brooks being referenced
Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas.
1992
AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorder
2011
Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders
2012
Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety
2016
The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents
2014
Sulfonamide resistance gene for plant transformation
1990
Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts
1992
Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
1991
Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease
1992
Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue
1992
Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease
1992
Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
1993